Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Procuritas on its acquisition of We Select
Mandate

Vinge advises Procuritas on its acquisition of We Select

June 09, 2022 Intellectual Property M&A Banking and Finance Employment and Benefits Public Procurement IT, Telecommunications and Outsourcing

Vinge advises Procuritas Capital Investors in connection with its acquisition of a majority stake in The We Select Company AB (“We Select”), a fast-growing digital talent acquisition platform. Key management will retain significant ownership of the company after the transaction.

We Select was founded in 2011 as a traditional recruitment services company. After launching its digital talent attraction offering in 2016, the company quickly transformed its business model and focused entirely on the fast-growing talent acquisition segment – social media. We Select helps companies to attract and hire top talent easily by combining strategic employer branding, data-driven job advertising and automatic candidate management in one smart platform.

Vinge’s team mainly consisted of Jonas Johansson, Carl Sander, Linus Adolfsson (M&A), Seyran Sahin, Karl-Gustaw Tobola (Banking and Finance), Elin Broman (Employment), Arvid Axelryd, Anna Högsten (IP), Lisa Hörnqvist (IT & GDPR), Kristoffer Sällfors (Public Procurement) and Anna Ekdahl Roos (Project Assistant).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025